http://purl.org/np/RAXdz2tn7M... RAXdz2tn7M

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasAttributedTo wasAttributedTo

https://orcid.org/0000-0002-3668-2627 Elif Ozkan

Elif Ozkan

2022-10-13T11:51:46.724Z

http://purl.org/np/RAXdz2tn7M... RAXdz2tn7M

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#generatedAtTime generatedAtTime

2022-10-13T11:51:46.724418

Elif Ozkan

2022-10-13T11:51:46.724Z

http://purl.org/np/RAXdz2tn7M... RAXdz2tn7M

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

emdesivir is indicated for the treatment of adult and pediatric patients 28 days of age and older and weighing at least 3 kg for coronavirus disease 2019 (COVID-19) infection requiring hospitalization. It is also indicated for non-hospitalized patients with mild-to-moderate COVID-2019, who are at high risk for progression to severe COVI-19, including hospitalization or death.

Elif Ozkan

2022-10-13T11:51:46.724Z